Oxidized LDL mediates the release of fibroblast growth factor-1.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Arteriosclerosis, Thrombosis and Vascular Biology

• Publication date

  1997-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1161/01.ATV.17.3.445PMID 9102162
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Role of transiently altered sarcolemmal membrane permeability and basic fibroblast growth factor release in the hypertrophic response of adult rat ventricular myocytes to increased mechanical activity in vitro.

  1996cited by this paper
• The role of oxidized lipoproteins in atherogenesis.

  1996cited by this paper
• Regulation of basic fibroblast growth factor (bFGF) gene and protein expression following its release from sublethally injured endothelial cells

  1995cited by this paper
• The response-to-retention hypothesis of early atherogenesis.

  1995cited by this paper
• The Release of Fibroblast Growth Factor-1 from NIH 3T3 Cells in Response to Temperature Involves the Function of Cysteine Residues (*)

  1995cited by this paper
• Contraction-induced cell wounding and release of fibroblast growth factor in heart.

  1995cited by this paper
• Synthesis of an endogeneous lectin, galectin-1, by human endothelial cells is up-regulated by endothelial cell activation

  1995cited by this paper
• Molecular mechanisms of angiogenesis: fibroblast growth factor signal transduction

  1995cited by this paper
• Effect of alpha-tocopherol on restenosis after angioplasty in a model of experimental atherosclerosis.

  1995cited by this paper
• Nitric oxide mediates cytotoxicity and basic fibroblast growth factor release in cultured vascular smooth muscle cells. A possible mechanism of neovascularization in atherosclerotic plaques.

  1995cited by this paper
• Oxidized LDL induces monocytic cell expression of interleukin-8, a chemokine with T-lymphocyte chemotactic activity.

  1994cited by this paper
• 7 beta-hydroperoxycholest-5-en-3 beta-ol, a component of human atherosclerotic lesions, is the primary cytotoxin of oxidized human low density lipoprotein.

  1994cited by this paper
• Terminal complement proteins C5b-9 release basic fibroblast growth factor and platelet-derived growth factor from endothelial cells

  1994cited by this paper
• Oxidized lipoproteins, altered cell function and atherosclerosis.

  1994cited by this paper
• Distinct patterns of expression of fibroblast growth factors and their receptors in human atheroma and nonatherosclerotic arteries. Association of acidic FGF with plaque microvessels and macrophages.

  1993cited by this paper
• Inhibition of glutathione synthesis increases the toxicity of oxidized low-density lipoprotein to human monocytes and macrophages.

  1993cited by this paper
• Immunostaining of human autopsy aortas with antibodies to modified apolipoprotein B and apoprotein(a).

  1993cited by this paper
• Expression of basic and acidic fibroblast growth factors and their receptor in normal and atherosclerotic human arteries.

  1993cited by this paper
• Oxidized low density lipoprotein inhibits the migration of aortic endothelial cells in vitro

  1993cited by this paper
• Induction of murine macrophage growth by modified LDLs.

  1993cited by this paper
• Minimally modified low density lipoprotein-induced inflammatory responses in endothelial cells are mediated by cyclic adenosine monophosphate.

  1993cited by this paper
• Basic fibroblast growth factor, a protein devoid of secretory signal sequence, is released by cells via a pathway independent of the endoplasmic reticulum‐Golgi complex

  1992cited by this paper
• Heat shock induces the release of fibroblast growth factor 1 from NIH 3T3 cells.

  1992cited by this paper
• Elimination of smooth muscle cells in experimental restenosis: targeting of fibroblast growth factor receptors.

  1992cited by this paper
• Native and oxidized LDL enhances production of PDGF AA and the surface expression of PDGF receptors in cultured human smooth muscle cells.

  1992cited by this paper
• Modified low-density lipoproteins : diversity and biological relevance in atherogenesis

  1992cited by this paper
• Basic fibroblast growth factor enhances the coupling of intimal hyperplasia and proliferation of vasa vasorum in injured rat arteries.

  1992cited by this paper
• Role of oxidized human plasma low density lipoproteins in atherosclerosis: effects on smooth muscle cell proliferation

  1992cited by this paper
• Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor.

  1991cited by this paper
• Role of basic fibroblast growth factor in vascular lesion formation.

  1991cited by this paper
• Modified low density lipoproteins activate human macrophages to secrete immunoreactive endothelin

  1991cited by this paper
• Vascular response to basic fibroblast growth factor when infused onto the normal adventitia or into the injured media of the rat carotid artery.

  1991cited by this paper
• Differential expression in Escherichia coli of the alpha and beta forms of heparin-binding acidic fibroblast growth factor-1: potential role of RNA secondary structure.

  1991cited by this paper
• Acidic fibroblast growth factor promotes vascular repair.

  1991cited by this paper
• Basic fibroblast growth factor is efficiently released from a cytolsolic storage site through plasma membrane disruptions of endothelial cells

  1991cited by this paper
• Differential expression in Escherichia coli of the α and β forms of heparin-binding acidic fibroblast growth factor-1: potential role of RNA secondary structure

  1991cited by this paper
• Oxidized low‐density lipoprotein is chemotactic for arterial smooth muscle cells in culture

  1990cited by this paper
• Minimally modified low density lipoprotein stimulates monocyte endothelial interactions.

  1990cited by this paper
• Basic fibroblast growth factor stimulates endothelial regrowth and proliferation in denuded arteries.

  1990cited by this paper
• The fibroblast growth factor family.

  1990cited by this paper
• Detection of high levels of heparin binding growth factor-1 (acidic fibroblast growth factor) in inflammatory arthritic joints

  1990cited by this paper
• Molecular and biochemical characterization of the human trk proto-oncogene

  1989cited by this paper
• Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man.

  1989cited by this paper
• Rapid redistribution of Golgi proteins into the ER in cells treated with brefeldin A: Evidence for membrane cycling from Golgi to ER

  1989cited by this paper
• Effects of irradiation on the release of growth factors from cultured bovine, porcine, and human endothelial cells.

  1989cited by this paper
• Regulation of extracellular matrix RNA levels in cultured smooth muscle cells. Relationship to cellular quiescence.

  1989cited by this paper
• The heparin-binding (fibroblast) growth factor family of proteins.

  1989cited by this paper
• Growth factors are released by mechanically wounded endothelial cells

  1989cited by this paper
• Injury‐induced release of basic fibroblast growth factor from bovine aortic endothelium

  1989cited by this paper
• Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis.

  1988cited by this paper
• Expression of acidic fibroblast growth factor cDNA confers growth advantage and tumorigenesis to Swiss 3T3 cells.

  1988cited by this paper
• Malondialdehyde-altered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits.

  1988cited by this paper
• Angiogenic factors.

  1987cited by this paper
• Toxicity of oxidized low‐density lipoprotein to cultured fibroblasts is selective for S phase of the cell cycle

  1987cited by this paper
• Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis.

  1987cited by this paper
• Multiple forms of endothelial cell growth factor. Rapid isolation and biological and chemical characterization.

  1985cited by this paper
• Endothelial cell-derived chemotactic activity for mouse peritoneal macrophages and the effects of modified forms of low density lipoprotein.

  1985cited by this paper
• Low density lipoprotein cytotoxicity induced by free radical peroxidation of lipid.

  1983cited by this paper
• Lipoprotein Oxidation and Lipoprotein‐lnduced Cytotoxicity

  1983cited by this paper
• Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter.

  1982cited by this paper
• Injury to human endothelial cells in culture induced by low density lipoproteins.

  1979cited by this paper
• LDL-induced cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cells in culture.

  1979cited by this paper
• The effects of body position, ganglionic blockade and norepinephrine on the pulmonary capillary bed.

  1960cited by this paper
• The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum.

  1955cited by this paper
• Basic Fibroblast Growth Factor Stimulates Endothelial Regrowth and Proliferation in Denuded Arteries

  year unknowncited by this paper

• Progress in the Cross-Organ Biomarker oxLDL in Promoting Pathological Neovascular Diseases.

  2026cites this paper
• LncRNA/CircRNA-miRNA-mRNA Axis in Atherosclerotic Inflammation: Research Progress.

  2023cites this paper
• miR-188-3p Inhibits Vascular Smooth Muscle Cell Proliferation and Migration by Targeting Fibroblast Growth Factor 1 (FGF1)

  2020cites this paper
• Fibroblast growth factor (FGF) and FGF receptor families in bone

  2020cites this paper
• Increased irisin versus reduced fibroblast growth factor1 (FGF1) in relation to adiposity, atherogenicity and hematological indices in metabolic syndrome patients with and without prediabetes

  2019cites this paper
• TUG1 knockdown ameliorates atherosclerosis via up-regulating the expression of miR-133a target gene FGF1.

  2018cites this paper
• The Role and Potential Therapeutic Implications of the Fibroblast Growth Factors in Energy Balance and Type 2 Diabetes

  2017cites this paper
• Effect of oxidized low-density lipoprotein on the expression of the prorenin receptor in human aortic smooth muscle cells.

  2015cites this paper
• Losartan alleviates hyperuricemia-induced atherosclerosis in a rabbit model.

  2015cites this paper
• FGF1 Mediates Overnutrition-Induced Compensatory β-Cell Differentiation

  2015cites this paper
• Indices of Cardiovascular Function Derived from Peripheral Pulse Wave Analysis Using Radial Applanation Tonometry in HIV Positive Patients from Mthatha District of South Africa

  2015cites this paper
• AHNAK2 Participates in the Stress‐Induced Nonclassical FGF1 Secretion Pathway

  2015cites this paper
• A Network Map of FGF-1/FGFR Signaling System

  2014cites this paper
• Hypothyroidism and Atherosclerosis : From Etiology to Pathophysiology

  2014cites this paper
• Protein-Phospholipid Interactions in Nonclassical Protein Secretion: Problem and Methods of Study

  2013cites this paper
• Integrative pathway dissection of molecular mechanisms of moxLDL-induced vascular smooth muscle phenotype transformation

  2013cites this paper
• Oxidative Stress and Heart Failure in Altered Thyroid States

  2012cites this paper
• Phosphatidylserine externalization and membrane blebbing are involved in the nonclassical export of FGF1

  2012cites this paper
• Age‐related modification of antioxidant enzyme activities in relation to cardiovascular risk factors

  2012cites this paper
• Oxidized Low-Density Lipoprotein and Atherosclerosis Implications in Antioxidant Therapy

  2011cites this paper
• NMR characterization of copper and lipid interactions of the C2B domain of synaptotagmin I-relevance to the non-classical secretion of the human acidic fibroblast growth factor (hFGF-1).

  2010cites this paper
• Protein folding does not prevent the nonclassical export of FGF1 and S100A13.

  2009cites this paper
• Oxidative risk for atherothrombotic cardiovascular disease.

  2009cites this paper
• Role of quercetin in cardiovascular diseases

  2008cites this paper
• Critical Reviews in Clinical Laboratory Sciences

  2008cites this paper
• FGF-1: From Biology Through Engineering to Potential Medical Applications

  2008cites this paper
• FGF-1: from biology through engineering to potential medical applications.

  2008cites this paper
• Chronic hyperglicemia and nitric oxide bioavailability play a pivotal role in pro-atherogenic vascular modifications

  2007cites this paper
• ["Systems Biology Analysis of Macrophage Foam Cells: Finding a Novel Function for Peroxiredoxin I"]

  2007cites this paper
• Flavonoids as Potent Phytochemicals in Cardiovascular Diseases Prevention

  2007cites this paper
• Release of FGF1 and p40 synaptotagmin 1 correlates with their membrane destabilizing ability.

  2006cites this paper
• Anemia, renal transplantation, and the anemia paradox.

  2006cites this paper
• Autoantibodies to oxidized LDL and cardiovascular risk: the Framingham Offspring Study.

  2006cites this paper
• ISG15: a ubiquitin-like enigma.

  2005cites this paper
• Prehospital thrombolysis: a reappraisal.

  2004cites this paper
• Modulation of growth factor gene expression in vascular cells by oxidative stress.

  2004cites this paper
• CHAPTER 327 – Nonclassical Pathways of Protein Export

  2003cites this paper
• The non-classical export routes: FGF1 and IL-1α point the way

  2003cites this paper
• Low Density Lipoproteins Interact With Acidic Fibroblast Growth Factor and Modify Its Function

  2003cites this paper
• Macrophage-Granulocyte Colony-Stimulating Factor and Fibroblast Growth Factor in the Blood of Patients with Hyperlipoproteinemia

  2003cites this paper
• The non-classical export routes: FGF1 and IL-1alpha point the way.

  2003cites this paper
• Pathogenesis of atherosclerosis: A multifactorial process.

  2002cites this paper
• Antioxidant N-acetylcysteine inhibits vasoactive agents-potentiated mitogenic effect of mildly oxidized LDL on vascular smooth muscle cells.

  2002cites this paper
• Smooth muscle cell proliferation induced by oxidized LDL-borne lysophosphatidylcholine. Evidence for FGF-2 release from cells not extracellular matrix.

  2002cites this paper
• Identification of genes induced by oxidized phospholipids in human aortic endothelial cells.

  2002cites this paper
• Association between the --514 C-->T polymorphism of the hepatic lipase gene promoter and unstable carotid plaque in patients with severe carotid artery stenosis.

  2002cites this paper
• Pathogenesis of atherosclerosis: A multifactorial process

  2002influential citation
• Oxidized LDL-induced apoptosis.

  2002cites this paper
• Potential role of leptin in angiogenesis: leptin induces endothelial cell proliferation and expression of matrix metalloproteinases in vivo and in vitro

  2001cites this paper
• Growth-promoting effects of oxidized low density lipoprotein.

  2001cites this paper
• The Comparative Release of FGF1 by Hypoxia and Temperature Stress

  2001cites this paper
• Increased expression and activation of stress-activated protein kinases/c-Jun NH(2)-terminal protein kinases in atherosclerotic lesions coincide with p53.

  2000cites this paper
• Cell Cycle Proteins and Atherosclerosis

  2000cites this paper
• Requirement of Phosphatidylinositol 3-Kinase Activity for Translocation of Exogenous aFGF to the Cytosol and Nucleus*

  2000cites this paper
• Regulation of proliferation-survival decisions is controlled by FGF1 secretion in retinal pigmented epithelial cells

  2000cites this paper
• Expression of leptin receptor (Ob-R) in human atherosclerotic lesions: potential role in intimal neovascularization.

  2000cites this paper
• Regulation of cell growth by oxidized LDL.

  2000cites this paper
• Low density lipoproteins in human plasma make vascular smooth muscle cells resistant to growth inhibition by heparin.

  2000cites this paper
• Oxidants and antioxidants in atherogenesis. An appraisal.

  1999cites this paper
• Oxidative Stress in Uremia: Impact on Cardiac Disease in Dialysis Patients

  1999cites this paper
• Cholesterol or triglyceride loading of human monocyte-derived macrophages by incubation with modified lipoproteins does not induce tissue factor expression.

  1999cites this paper
• NATIVE LDL THAT IS OFTEN USED IN IN VITRO STUDIES MAY NOT REPRESENT NATIVE LDL IN PLASMA

  1999cites this paper
• Fibroblast growth factors as multifunctional signaling factors.

  1999cites this paper
• Induction of macrophage VEGF in response to oxidized LDL and VEGF accumulation in human atherosclerotic lesions.

  1998cites this paper
• Inflammation, Lipids, and Free Radicals: Lessons Learned from the Atherogenic Process

  1998cites this paper
• Gingivitis : An Inflammatory Periodontal Disease

  year unknowncites this paper